On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles
Haisco Pharmaceutical Group (002653.SZ) has obtained a new indication for the innovative drug HSK39797 tablet in the "Drug Clinical Trial Approval Notice".
CMSC: Significant changes in supply and demand situation, prices of wet diaphragm entering an upward trend.
Financial Report Preview | Farewell to Burning Money for Expansion? Walt Disney Company (DIS.US) "Upgrade and Improve" Strategy Faces Key Test
Haisco Pharmaceutical Group (002653.SZ) has obtained a new indication for the innovative drug HSK39797 tablet in the "Drug Clinical Trial Approval Notice".
CMSC: Significant changes in supply and demand situation, prices of wet diaphragm entering an upward trend.
Financial Report Preview | Farewell to Burning Money for Expansion? Walt Disney Company (DIS.US) "Upgrade and Improve" Strategy Faces Key Test
RECOMMEND
Younger consumers are dining out less at Chipotle and Cava while still buying Coach handbags
10/11/2025
Target’s deteriorating in-store experience risks recovery — retailer bets on a refined fulfillment model to fix it
10/11/2025
China suspends approval ban on exports of certain metals used in chip and electronics manufacturing to the U.S.
10/11/2025
